Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer
about
Evidence that SOX2 overexpression is oncogenic in the lungThe molecular mechanism governing the oncogenic potential of SOX2 in breast cancerExploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brainThe role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lungLong non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesisCharacterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemiaMice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndromeThe Effect of MicroRNA-375 Overexpression, an Inhibitor of Helicobacter pylori-Induced Carcinogenesis, on lncRNA SOX2OT.Early lung cancer diagnosis by biosensors.The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I.PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme.Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter.Evidence for a bias toward intracellular antigens in the local humoral anti-tumor immune response of a colorectal cancer patient revealed by phage display.Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma.Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library.Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromesThe sentinel within: exploiting the immune system for cancer biomarkers.Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course.Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biologyGalectin-1 and its involvement in hepatocellular carcinoma aggressivenessBig Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinomaDownregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancerEmerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancerActivation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.Immunity to stemness genes in human cancer.Sexual phenotype differences in zic2 mRNA abundance in the preoptic area of a protogynous teleost, Thalassoma bifasciatum.SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis.A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing.Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges.Interaction of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis.Clinical validation of an autoantibody test for lung cancer.Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.
P2860
Q21091126-95CAFF07-C76F-4D33-A5CE-697863F6DD98Q24309520-41539982-4804-43A9-B007-2C9494373608Q24561943-35DB3FEE-B823-4F97-BBFA-3F4347D01148Q26822879-152A0018-341C-4DB7-AD97-7E923AB33F45Q28082535-059B9813-6879-4785-A47D-6E3B3F3F2A53Q28178372-54E0740A-C845-4E6B-B78F-BD790759E0F5Q28508181-8DDE1F58-EEDF-49C4-9C10-32A52FDEE324Q30371417-7E177A98-CB8D-402C-864C-2997520ACEE8Q30449799-17AED88A-5632-42AB-90F5-473B06AB50C3Q30681365-B7B4FA09-6FBE-4DDB-A8F4-46C3F6E37534Q30690737-63C1F3F2-7C0D-4CFB-BCD8-E447C36C8391Q30855737-A2BA73AB-3A29-4815-A27B-36895565C045Q30945386-66F89EC4-F232-4DFB-876C-52555DA6BEF0Q31004523-49869CC9-E4DA-42DD-ABBE-B7D63E11CF25Q31115820-B801DDE9-C722-4D74-9310-FFE10CC38D94Q33184085-F0F261E3-F52D-4C35-BB25-82CDDE86E4B0Q33214731-019F25D7-5AC3-4713-94BC-19BBE3DEE669Q33216878-5A8620B6-31F5-4F0C-B96A-B707BB57E8E9Q33221191-C55720D7-FE67-4694-83FC-E6DFB74775CCQ33230009-57B0B245-1A1B-41F9-B2CC-3F2CD1FFBD21Q33597213-2CDCABF2-B0F2-4E06-BF24-C840E40DA799Q33692511-2D2A485A-76E1-4FB5-AC8C-90DD9682BA4EQ33802553-4D8D65ED-4C55-4DBA-A8AF-2502F77A0B1EQ33806378-DA254BD7-7A3A-4422-85AF-CF1C77A1030AQ33863504-9B29C3F1-E139-4FAD-B6A8-D4BB8D362246Q33875325-74EFB53D-F1F2-4452-94DF-4D20C4455A54Q33901136-F8EC6A88-BDE1-4925-A7A5-A7DC523C2348Q33933918-4010739F-0CE3-4C66-B307-470C6A08918BQ33943241-85BDA9FA-72B9-405E-B726-90450337E5E3Q33986158-60C46C2A-6F0B-444C-9A07-4026A91D828AQ34022836-FA2E33B2-E6B2-4CBA-945C-C757F08F034DQ34049184-4311E18E-2DBE-49E1-8204-AF571F44149DQ34089736-BCAC558F-55E3-4275-B9F3-8B6FD836FAE5Q34130453-A790FFFF-6EEA-4763-9BD9-1E2993F79269Q34151620-CFA50403-DBBB-4FEE-A0B0-AF50B8D1F50CQ34154152-B6441C09-97D9-40DE-A5B1-A1D6295DF494Q34537374-574FB750-8F71-4713-95C0-E764DB4A793FQ34639948-8C36E9A5-3562-4DE1-801F-E03103B875CCQ34826137-A75F5F4B-2964-4C0F-9A49-8ACFEF441E80Q35170389-11A36055-4C8F-43B6-B11B-83C6C4BA3898
P2860
Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Serological identification of ...... gens in small cell lung cancer
@ast
Serological identification of ...... gens in small cell lung cancer
@en
Serological identification of ...... gens in small cell lung cancer
@nl
type
label
Serological identification of ...... gens in small cell lung cancer
@ast
Serological identification of ...... gens in small cell lung cancer
@en
Serological identification of ...... gens in small cell lung cancer
@nl
prefLabel
Serological identification of ...... gens in small cell lung cancer
@ast
Serological identification of ...... gens in small cell lung cancer
@en
Serological identification of ...... gens in small cell lung cancer
@nl
P2093
P2860
P3181
P356
P1476
Serological identification of ...... gens in small cell lung cancer
@en
P2093
E Stockert
M J Scanlan
N K Altorki
R S Keresztes
P2860
P304
P3181
P356
10.1073/PNAS.97.8.4198
P407
P577
2000-04-11T00:00:00Z